HRMY - Harmony Biosciences Holdings Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.747B

Cash

372.4M

Avg Qtr Burn

N/A

Short % of Float

23.26%

Insider Ownership

19.77%

Institutional Own.

91.52%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
WAKIX® (pitolisant) Details Excessive daytime sleepiness, Genetic disorder, Cataplexy, Narcolepsy, Prader-Willi syndrome	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WAKIX® (pitolisant) Details Narcolepsy	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WAKIX® (pitolisant) Details EDS in Idiopathic Hypersomnia	sNDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WAKIX® (pitolisant) Details Rare genetic disease, Genetic disorder, Prader-Willi syndrome, Excessive daytime sleepiness	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zygel (ZYN002 CBD Gel) Details Rare genetic disease, Genetic disorder, Fragile X syndrome	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zygel (ZYN002 CBD Gel) Details Rare genetic disease, Genetic disorder, Deletion Syndrome , 22q11.2 deletion syndrome	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EPX-100 [clemizole hydrochloride] Details Dravet syndrome	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WAKIX® (pitolisant) Details Muscle weakness, Muscle degeneration, Myotonic Dystrophy Type 1	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TPM-1116 [orexin-2 receptor agonist] Details Narcolepsy, Sleep-wake disorder	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.